HIV co-receptor inhibitors as novel class of anti-HIV drugs

被引：31

作者：

Schols, Dominique ^{[1
]}

机构：

[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium

来源：

ANTIVIRAL RESEARCH | 2006年 / 71卷 / 2-3期

关键词：

CCR5; CXCR4; antagonist; HIV; chemokine receptor; gp120; envelope; HUMAN-IMMUNODEFICIENCY-VIRUS; CHEMOKINE RECEPTOR CXCR4; SMALL-MOLECULE INHIBITOR; HUMAN LYMPHOID-TISSUE; INFECTION IN-VITRO; TYPE-1; REPLICATION; CCR5; ANTAGONIST; HIGHLY POTENT; TROPIC HIV-1; SELECTIVE-INHIBITION;

D O I：

10.1016/j.antiviral.2006.04.009

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Entry inhibitors constitute a new class of drugs to treat infection by human immunodeficiency virus type 1 (HIV-1). The first member of this class, enfuvirtide, previously known as T-20 and targeting gp41, has now been licensed for therapeutic use. Several other entry inhibitors are in various stages of pre-clinical or clinical development. In this review we focus on the chemokine receptor inhibitors targeting CCR5 and CXCR4 that are the main HIV co-receptors for viral entry. (c) 2006 Elsevier B.V. All rights reserved.

引用

页码：216 / 226

页数：11

共 97 条

[91] The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity [J].

Trkola, A ;

Gordon, C ;

Matthews, J ;

Maxwell, E ;

Ketas, T ;

Czaplewski, L ;

Proudfoot, AEI ;

Moore, JP .

JOURNAL OF VIROLOGY, 1999, 73 (08) :6370-6379

[92] Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140 [J].

Trkola, A ;

Ketas, TJ ;

Nagashima, KA ;

Zhao, L ;

Cilliers, T ;

Morris, L ;

Moore, JP ;

Maddon, PJ ;

Olson, WC .

JOURNAL OF VIROLOGY, 2001, 75 (02) :579-588

[93] HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use [J].

Trkola, A ;

Kuhmann, SE ;

Strizki, JM ;

Maxwell, E ;

Ketas, T ;

Morgan, T ;

Pugach, P ;

Xu, S ;

Wojcik, L ;

Tagat, J ;

Palani, A ;

Shapiro, S ;

Clader, JW ;

McCombie, S ;

Reyes, GR ;

Baroudy, BM ;

Moore, JP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) :395-400

[94] CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 [J].

Trkola, A ;

Dragic, T ;

Arthos, J ;

Binley, JM ;

Olson, WC ;

Allaway, GP ;

ChengMayer, C ;

Robinson, J ;

Maddon, PJ ;

Moore, JP .

NATURE, 1996, 384 (6605) :184-187

[95]

VANDERRYST E, 2005, 1 INT WORKSH TARG HI

[96] CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 [J].

Wu, LJ ;

Gerard, NP ;

Wyatt, R ;

Choe, H ;

Parolin, C ;

Ruffing, N ;

Borsetti, A ;

Cardoso, AA ;

Desjardin, E ;

Newman, W ;

Gerard, C ;

Sodroski, J .

NATURE, 1996, 384 (6605) :179-183

[97] Binding of ALX40-4C to APJ, a CNS-based receptor, inhibits its utilization as a co-receptor by HIV-1 [J].

Zhou, NM ;

Fang, JH ;

Acheampong, E ;

Mukhtar, M ;

Pomerantz, RJ .

VIROLOGY, 2003, 312 (01) :196-203

← 1 2 3 4 5 6 7 8 9 10 →